Business News: Organon to Buy Dermavant including Tapinarof Cream, 1%(Vtama)
The Dermatology Digest
SEPTEMBER 18, 2024
Food and Drug Administration (FDA) in May 2022. This is an unparalleled opportunity for continued growth and innovation for Dermavant, preserving our values and vision and allowing them to thrive in the new structure at Organon. Roivant was represented by Freshfields Bruckhaus Deringer LLP as legal advisor and Goldman Sachs & Co.
Let's personalize your content